Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,200 | 1 | 41.7% |
| Food and Beverage | $1,200 | 27 | 41.7% |
| Travel and Lodging | $477.00 | 2 | 16.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,238 | 2 | $0 (2023) |
| Veloxis Pharmaceuticals, Inc. | $794.53 | 23 | $0 (2023) |
| TransMedics, Inc. | $439.00 | 1 | $0 (2023) |
| INTUITIVE SURGICAL, INC. | $282.46 | 3 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $122.83 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $188.29 | 2 | SANOFI-AVENTIS U.S. LLC ($122.83) |
| 2023 | $1,739 | 6 | Medtronic, Inc. ($1,238) |
| 2022 | $127.75 | 2 | Veloxis Pharmaceuticals, Inc. ($127.75) |
| 2021 | $282.34 | 5 | Veloxis Pharmaceuticals, Inc. ($169.61) |
| 2020 | $218.90 | 7 | Veloxis Pharmaceuticals, Inc. ($114.63) |
| 2019 | $220.94 | 7 | Veloxis Pharmaceuticals, Inc. ($220.94) |
| 2018 | $99.56 | 1 | Veloxis Pharmaceuticals, Inc. ($99.56) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $122.83 | General |
| Category: Oncology | ||||||
| 10/08/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $65.46 | General |
| Category: SURGERY | ||||||
| 10/18/2023 | TransMedics, Inc. | Organ Care System (Device) | Travel and Lodging | Cash or cash equivalent | $439.00 | General |
| Category: Device | ||||||
| 05/12/2023 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 04/24/2023 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $38.00 | General |
| 02/14/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: TRANSPLANTATION | ||||||
| 01/31/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: TRANSPLANTATION | ||||||
| 01/10/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: TRANSPLANTATION | ||||||
| 10/19/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Immunosuppresant | ||||||
| 03/17/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $105.50 | General |
| Category: Immunosuppresant | ||||||
| 11/30/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $112.73 | General |
| Category: SURGERY | ||||||
| 09/21/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Immunosuppresant | ||||||
| 08/17/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Immunosuppresant | ||||||
| 08/10/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Immunosuppresant | ||||||
| 07/21/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $101.54 | General |
| Category: Immunosuppresant | ||||||
| 09/15/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $23.61 | General |
| Category: Immunosuppressant | ||||||
| 03/17/2020 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $104.27 | General |
| Category: SURGERY | ||||||
| 03/10/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $17.22 | General |
| Category: Immunosuppressant | ||||||
| 02/18/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $17.84 | General |
| Category: Immunosuppressant | ||||||
| 02/11/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: Immunosuppressant | ||||||
| 01/21/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: Immunosuppressant | ||||||
| 01/14/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $19.46 | General |
| Category: Immunosuppressant | ||||||
| 12/17/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Immunosuppressant | ||||||
| 12/10/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Immunosuppressant | ||||||
| 11/26/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Immunosuppressant | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 52 | 193 | $48,872 | $14,033 |
| 2022 | 2 | 56 | 173 | $45,543 | $12,633 |
| 2021 | 5 | 124 | 363 | $93,761 | $28,179 |
| 2020 | 8 | 195 | 602 | $671,412 | $123,443 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 172 | $38,880 | $11,544 | 29.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 17 | 21 | $9,992 | $2,489 | 24.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 134 | $28,363 | $8,338 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 22 | 39 | $17,180 | $4,295 | 25.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 252 | $51,345 | $15,876 | 30.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 28 | 43 | $18,418 | $5,547 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 27 | 40 | $12,280 | $3,275 | 26.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 13 | 13 | $7,524 | $2,132 | 28.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 15 | 15 | $4,194 | $1,349 | 32.2% |
| 47135 | Transplantation of donor liver to anatomic position | Facility | 2020 | 15 | 15 | $340,995 | $57,593 | 16.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 58 | 425 | $84,224 | $27,306 | 32.4% |
| 50360 | Transplantation of donor kidney | Facility | 2020 | 11 | 11 | $94,600 | $23,170 | 24.5% |
| 50605 | Insertion of stent in urinary duct (ureter) | Facility | 2020 | 11 | 11 | $39,939 | $5,214 | 13.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 42 | 79 | $23,708 | $5,138 | 21.7% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 32 | 34 | $9,270 | $2,995 | 32.3% |
| 47143 | Preparation of donor liver for transplantation | Facility | 2020 | 15 | 15 | $76,510 | $1,255 | 1.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 11 | 12 | $2,166 | $772.26 | 35.7% |
About Dr. Mohamed Akoad, MD
Dr. Mohamed Akoad, MD is a Surgery healthcare provider based in Burlington, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295751949.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohamed Akoad, MD has received a total of $2,877 in payments from pharmaceutical and medical device companies, with $188.29 received in 2024. These payments were reported across 30 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($1,200).
As a Medicare-enrolled provider, Akoad has provided services to 427 Medicare beneficiaries, totaling 1,331 services with total Medicare billing of $178,288. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Location Burlington, MA
- Active Since 07/14/2006
- Last Updated 10/11/2011
- Taxonomy Code 208600000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295751949
Products in Payments
- Envarsus (Drug) $632.93
- Organ Care System (Device) $439.00
- Da Vinci Surgical System (Device) $282.46
- THYMOGLOBULIN (Biological) $122.83
- Envarsus XR (SP) (Drug) $99.56
- ENVARSUS (Drug) $62.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Burlington
Reuben Shin, M.d, M.D
Surgery — Payments: $118,761
Peter Marcello, Md, MD
Surgery — Payments: $82,842
David Kleiman, Md, MD
Surgery — Payments: $50,413
Dr. Isami Sakai, D.o, D.O
Surgery — Payments: $31,305
Rocco Ricciardi, Md, MD
Surgery — Payments: $23,378
Diego Pabon, M.d, M.D
Surgery — Payments: $20,681